overview
Active Projects
To date, the Consortium has launched 10 projects in areas as diverse as Alzheimer’s disease, cardiovascular disease and breast cancer; a number of other promising projects are also moving forward for implementation. The consortium completed its first project, The Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy, in 2009.
join us 